Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro.
AIDS Res Hum Retroviruses
; 4(1): 71-81, 1988 Feb.
Article
in En
| MEDLINE
| ID: mdl-3365357
ABSTRACT
The antiviral xanthate compound tricyclodecan-9-yl-xanthogenate (code name D609) is capable of inhibiting DNA and RNA viruses in vitro. It can also inhibit the shedding of infectious HIV into the tissue culture medium from chronically infected lymphoma cells (KE37-III) as shown by infectivity assays and Western blots of the supernatant. HIV-specific proteins, however, were accumulated intracellularly. The initiation of a de novo HIV replication after infection of permissive KE37-1 cells was completely inhibited at concentrations of D609 which still permitted mitotic divisions of the cells. Furthermore, the selective antiviral activity of the xanthate compound was evidenced by the absence of HIV replicative intermediate DNA. The expression of cellular genes, such as c-myc, remained unimpaired within these cells.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiones
/
Virus Replication
/
Bridged-Ring Compounds
/
HIV
Limits:
Humans
Language:
En
Journal:
AIDS Res Hum Retroviruses
Journal subject:
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Year:
1988
Type:
Article